George Francis Tidmarsh is an entrepreneur and businessperson who founded 5 companies, which include: Horizon Pharma, Inc., Threshold Pharmaceuticals, Inc. and Horizon Therapeutics, Inc. and who has been at the head of 9 different companies. Currently, Dr. Tidmarsh occupies the position of Chairman of Prospect Therapeutics, Inc. and Chairman for Revelation Biosciences, Inc., Chairman at Revelation Biosciences Sub, Inc. (a subsidiary of Revelation Biosciences, Inc.). George Francis Tidmarsh is also on the board of Lucile Packard Foundation for Children’s Health and Citizens Oncology Foundation and Associate Professor-Neonatology at Stanford University School of Medicine.
In the past Dr. Tidmarsh occupied the position of President, CEO, Secretary & Director at La Jolla Pharmaceutical Co., President & Chief Executive Officer for Nuveta, Inc. (he founded the company in 2009), Chief Executive Officer at Solana Therapeutics, Inc., Chief Scientific Officer & Senior Vice President at Spectrum Pharmaceuticals, Inc. and Chief Executive Officer for Metronome Therapeutics, Inc. (a subsidiary of Spectrum Pharmaceuticals, Inc.), Principal at Gilead Sciences, Inc., President at Horizon Pharma, Inc. (he founded the company in 2005), President at Threshold Pharmaceuticals, Inc. (he founded the company in 2001), Chief Medical Officer for Coulter Pharmaceuticals, Inc., Principal at SEQUUS Pharmaceuticals, Inc., Principal at Systemix, Inc. and Director at Horizon Therapeutics, Inc.
Dr. Tidmarsh received a doctorate from Stanford University and a doctorate from Stanford University School of Medicine.